Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

Background: The CXCR4/SDF-1α axis plays a vital role in the retention of stem cells within the bone marrow and downstream activation of cell survival signaling pathways. LY2510924, a second generation CXCR4, showed significant anti-leukemia activity in a murine AML model. Methods: We conducted a pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Boddu, Prajwal, Borthakur, Gautam, Koneru, Mythili, Huang, Xuelin, Naqvi, Kiran, Wierda, William, Bose, Prithviraj, Jabbour, Elias, Estrov, Zeev, Burger, Jan, Alvarado, Yesid, Deshmukh, April, Patel, Ami, Cavazos, Antonio, Han, Lina, Cortes, Jorge E., Kantarjian, Hagop, Andreeff, Michael, Konopleva, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167965/
https://www.ncbi.nlm.nih.gov/pubmed/30319961
http://dx.doi.org/10.3389/fonc.2018.00369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167965/
https://www.ncbi.nlm.nih.gov/pubmed/30319961
http://dx.doi.org/10.3389/fonc.2018.00369

Ejemplares similares